3,4-methylenedioxyamphetamine has been researched along with ergoline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breeding, M; Sanders-Bush, E | 1 |
Chiodo, LA; Freeman, AS; Kelland, MD | 1 |
2 other study(ies) available for 3,4-methylenedioxyamphetamine and ergoline
Article | Year |
---|---|
Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Antiparkinson Agents; Cells, Cultured; Choroid Plexus; DOM 2,5-Dimethoxy-4-Methylamphetamine; Epithelial Cells; Ergolines; Hallucinogens; Male; Phosphatidylinositols; Quipazine; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Stereoisomerism | 1991 |
(+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Apomorphine; Biogenic Amines; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Quinpirole; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra | 1989 |